Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma
Background Previous studies have shown that RNA Polymerase III Subunit G (POLR3G) has oncogenic effects in cultured cells and mice. However, the role of POLR3G in transitional cell carcinoma (TCC) has not been reported. This study explores the potential of POLR3G as a novel molecular marker for TCC....
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2020-11-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/10281.pdf |
| _version_ | 1827608913265033216 |
|---|---|
| author | Xianhui Liu Weiyu Zhang Huanrui Wang Chin-Hui Lai Kexin Xu Hao Hu |
| author_facet | Xianhui Liu Weiyu Zhang Huanrui Wang Chin-Hui Lai Kexin Xu Hao Hu |
| author_sort | Xianhui Liu |
| collection | DOAJ |
| description | Background Previous studies have shown that RNA Polymerase III Subunit G (POLR3G) has oncogenic effects in cultured cells and mice. However, the role of POLR3G in transitional cell carcinoma (TCC) has not been reported. This study explores the potential of POLR3G as a novel molecular marker for TCC. Methods The RNA sequencing data and clinical information of patients with TCC were downloaded from The Cancer Genome Atlas official website. Transcriptome analysis was performed as implemented in the edgeR package to explore whether POLR3G was up-regulated in TCC tissues compared to normal bladder tissues. The expression of POLR3G in bladder cancer cell line T24 and human uroepithelial cell line SV-HUC-1 were detected via quantitative real time polymerase chain reaction (qRT-PCR). Correlations between POLR3G expression and clinicopathological characteristics were analyzed using Mann-Whitney U test or Kruskal-Wallis H test. Clinicopathological characteristics associated with overall survival were explored using the Kaplan-Meier method and Cox regression analyses. Gene set enrichment analysis (GSEA) was performed to explore the associated gene sets enriched in different POLR3G expression phenotypes and the online tool Tumor IMmune Estimation Resource (TIMER) was used to explore the correlation between POLR3G expression and tumor immune infiltration in TCC. Results Transcriptome analysis showed that POLR3G was significantly up-regulated in TCC tissues compared to normal bladder tissues. Furthermore, qRT-PCR revealed high expression of POLR3G in T24 cells compared to SV-HUC-1 cells. Overall, POLR3G expression was associated with race, tumor status, tumor subtype, T classification, and pathological stage. Kaplan-Meier survival analysis revealed that higher POLR3G expression was associated with lower overall survival. The univariate Cox regression model revealed that age at diagnosis, pathological stage, and POLR3G expression were associated with prognosis of TCC patients. Further multivariate analyses identified these three clinicopathological characteristics as independent prognostic factors for overall survival. GSEA analysis showed that several gene sets associated with tumor development and metastasis, including TGF-β signaling, PI3K-AKT-mTOR signaling, and IL6-JAK-STAT3 signaling, were significantly enriched in POLR3G high expression phenotype. Immune infiltration analysis revealed that the expression of POLR3G was significantly correlated with infiltrating levels of immune cells, including CD8+ T cells, neutrophils, and dendritic cells; and the expression of POLR3G was also significantly correlated with the expression of immune checkpoint molecules, such as PD1, PD-L1, PD-L2, CTLA4, LAG3, HAVCR2, and TIGIT. Conclusions POLR3G was up-regulated in TCC and high POLR3G expression correlated with poor prognosis. POLR3G can potentially be used as a prognostic marker for TCC and might be of great value in predicting the response to immunotherapy. |
| first_indexed | 2024-03-09T07:23:29Z |
| format | Article |
| id | doaj.art-f9f64460e0204c398feed504abf8e469 |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T07:23:29Z |
| publishDate | 2020-11-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-f9f64460e0204c398feed504abf8e4692023-12-03T07:14:44ZengPeerJ Inc.PeerJ2167-83592020-11-018e1028110.7717/peerj.10281Increased expression of POLR3G predicts poor prognosis in transitional cell carcinomaXianhui Liu0Weiyu Zhang1Huanrui Wang2Chin-Hui Lai3Kexin Xu4Hao Hu5Department of Urology, Peking University People’s Hospital, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaDepartment of Urology, Peking University People’s Hospital, Beijing, ChinaBackground Previous studies have shown that RNA Polymerase III Subunit G (POLR3G) has oncogenic effects in cultured cells and mice. However, the role of POLR3G in transitional cell carcinoma (TCC) has not been reported. This study explores the potential of POLR3G as a novel molecular marker for TCC. Methods The RNA sequencing data and clinical information of patients with TCC were downloaded from The Cancer Genome Atlas official website. Transcriptome analysis was performed as implemented in the edgeR package to explore whether POLR3G was up-regulated in TCC tissues compared to normal bladder tissues. The expression of POLR3G in bladder cancer cell line T24 and human uroepithelial cell line SV-HUC-1 were detected via quantitative real time polymerase chain reaction (qRT-PCR). Correlations between POLR3G expression and clinicopathological characteristics were analyzed using Mann-Whitney U test or Kruskal-Wallis H test. Clinicopathological characteristics associated with overall survival were explored using the Kaplan-Meier method and Cox regression analyses. Gene set enrichment analysis (GSEA) was performed to explore the associated gene sets enriched in different POLR3G expression phenotypes and the online tool Tumor IMmune Estimation Resource (TIMER) was used to explore the correlation between POLR3G expression and tumor immune infiltration in TCC. Results Transcriptome analysis showed that POLR3G was significantly up-regulated in TCC tissues compared to normal bladder tissues. Furthermore, qRT-PCR revealed high expression of POLR3G in T24 cells compared to SV-HUC-1 cells. Overall, POLR3G expression was associated with race, tumor status, tumor subtype, T classification, and pathological stage. Kaplan-Meier survival analysis revealed that higher POLR3G expression was associated with lower overall survival. The univariate Cox regression model revealed that age at diagnosis, pathological stage, and POLR3G expression were associated with prognosis of TCC patients. Further multivariate analyses identified these three clinicopathological characteristics as independent prognostic factors for overall survival. GSEA analysis showed that several gene sets associated with tumor development and metastasis, including TGF-β signaling, PI3K-AKT-mTOR signaling, and IL6-JAK-STAT3 signaling, were significantly enriched in POLR3G high expression phenotype. Immune infiltration analysis revealed that the expression of POLR3G was significantly correlated with infiltrating levels of immune cells, including CD8+ T cells, neutrophils, and dendritic cells; and the expression of POLR3G was also significantly correlated with the expression of immune checkpoint molecules, such as PD1, PD-L1, PD-L2, CTLA4, LAG3, HAVCR2, and TIGIT. Conclusions POLR3G was up-regulated in TCC and high POLR3G expression correlated with poor prognosis. POLR3G can potentially be used as a prognostic marker for TCC and might be of great value in predicting the response to immunotherapy.https://peerj.com/articles/10281.pdfTransitional cell carcinomaPOLR3GBiomarkerTCGATumor immue infiltrationPrognosis |
| spellingShingle | Xianhui Liu Weiyu Zhang Huanrui Wang Chin-Hui Lai Kexin Xu Hao Hu Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma PeerJ Transitional cell carcinoma POLR3G Biomarker TCGA Tumor immue infiltration Prognosis |
| title | Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma |
| title_full | Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma |
| title_fullStr | Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma |
| title_full_unstemmed | Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma |
| title_short | Increased expression of POLR3G predicts poor prognosis in transitional cell carcinoma |
| title_sort | increased expression of polr3g predicts poor prognosis in transitional cell carcinoma |
| topic | Transitional cell carcinoma POLR3G Biomarker TCGA Tumor immue infiltration Prognosis |
| url | https://peerj.com/articles/10281.pdf |
| work_keys_str_mv | AT xianhuiliu increasedexpressionofpolr3gpredictspoorprognosisintransitionalcellcarcinoma AT weiyuzhang increasedexpressionofpolr3gpredictspoorprognosisintransitionalcellcarcinoma AT huanruiwang increasedexpressionofpolr3gpredictspoorprognosisintransitionalcellcarcinoma AT chinhuilai increasedexpressionofpolr3gpredictspoorprognosisintransitionalcellcarcinoma AT kexinxu increasedexpressionofpolr3gpredictspoorprognosisintransitionalcellcarcinoma AT haohu increasedexpressionofpolr3gpredictspoorprognosisintransitionalcellcarcinoma |